You are reading one round. Fundz also knows which of your own LinkedIn connections can open this account.See it live →
Cardiovascular AI startup Corologic raises seed funding from Kakao Ventures and SNU Holdings to advance clinical validation and commercialization of its AngioFilm solution.
PRIVATESep 15, 2026•about 4 hours ago
Round Type
Seed
South KoreaManufacturingBiotechnologyHealth CareArtificial IntelligenceMedical DeviceMachine LearningImage Recognition
Investors
Snu HoldingsKakao Ventures
Description
Corologic, a cardiovascular imaging AI startup founded in May 2026, has raised seed funding from Kakao Ventures and SNU Holdings. The company will use the proceeds for multicenter clinical validation and regulatory approvals domestically and internationally. Corologic's AngioFilm technology uses AI-based video frame interpolation to reduce radiation exposure during coronary angiography procedures. The solution can integrate with existing angiography equipment without replacement, offering low adoption burden for healthcare providers.
Company Information
Company
Corologic
Location
South Korea
About
Corologic is a cardiovascular imaging AI startup founded in May 2026 by Professor Kang Si-hyuk of Seoul National University Bundang Hospital. The company develops AngioFilm, an AI solution using video frame interpolation technology to reduce radiation exposure during coronary angiography procedures. The solution analyzes blood vessel movement and medical devices to generate intermediate frames, allowing procedures to be performed with fewer X-ray images while maintaining image quality. AngioFilm integrates with existing angiography equipment without requiring hardware replacement.
Don't miss Corologic's next move
Get an email the moment Corologic raises, hires an exec, or expands, usually minutes after it happens.